Cargando…

Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury

BACKGROUND: Quelling microglial-induced excessive neuroinflammation is a potential treatment strategy across neurological disorders, including traumatic brain injury (TBI), and can be achieved by thalidomide-like drugs albeit this approved drug class is compromised by potential teratogenicity. Tetra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lecca, Daniela, Hsueh, Shih-Chang, Luo, Weiming, Tweedie, David, Kim, Dong Seok, Baig, Abdul Mannan, Vargesson, Neil, Kim, Yu Kyung, Hwang, Inho, Kim, Sun, Hoffer, Barry J., Chiang, Yung-Hsiao, Greig, Nigel H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987061/ https://www.ncbi.nlm.nih.gov/pubmed/36872339 http://dx.doi.org/10.1186/s12929-023-00907-5

Ejemplares similares

Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs
por: Peach, Megan L., et al.
Publicado: (2020)

Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Treatment for Traumatic Brain Injury
por: Hsueh, Shih Chang, et al.
Publicado: (2022)

Structural basis of thalidomide enantiomer binding to cereblon
por: Mori, Tomoyuki, et al.
Publicado: (2018)

3,6′- and 1,6′-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation
por: Tsai, Yan-Rou, et al.
Publicado: (2022)

(−)‐Phenserine tartrate (PhenT) as a treatment for traumatic brain injury
por: Greig, Nigel H., et al.
Publicado: (2019)

CRL4-Cereblon complex in Thalidomide Embryopathy: a translational investigation
por: Kowalski, Thayne Woycinck, et al.
Publicado: (2020)

(-)-Phenserine Ameliorates Contusion Volume, Neuroinflammation, and Behavioral Impairments Induced by Traumatic Brain Injury in Mice
por: Hsueh, Shih-Chang, et al.
Publicado: (2019)

Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6′-Dithiothalidomide on Traumatic Brain Injury
por: Batsaikhan, Buyandelger, et al.
Publicado: (2019)

Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments
por: Jung, Yoo Jin, et al.
Publicado: (2019)

Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation
por: Tweedie, David, et al.
Publicado: (2011)

Thalidomide‐induced teratogenesis: History and mechanisms
por: Vargesson, Neil
Publicado: (2015)

In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems
por: Beedie, Shaunna L., et al.
Publicado: (2016)

The Neuroprotective Effect of Thalidomide against Ischemia through the Cereblon-mediated Repression of AMPK Activity
por: Sawamura, Naoya, et al.
Publicado: (2018)

Thalidomide and its metabolite 5‐hydroxythalidomide induce teratogenicity via the cereblon neosubstrate PLZF
por: Yamanaka, Satoshi, et al.
Publicado: (2021)

De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives
por: Heim, Christopher, et al.
Publicado: (2019)

Evaluation of the influence of genetic variants in Cereblon gene on the response to the treatment of erythema nodosum leprosum with thalidomide
por: Costa, Perpétua do Socorro Silva, et al.
Publicado: (2022)

Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis
por: Lecca, Daniela, et al.
Publicado: (2022)

3,6′-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain Injury
por: Huang, Pen-Sen, et al.
Publicado: (2021)

Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian Rats
por: Yu, Yu-Wen, et al.
Publicado: (2018)

A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders
por: Kopp, Katherine O., et al.
Publicado: (2023)

The Thalidomide-Binding Domain of Cereblon Defines the CULT Domain Family and Is a New Member of the β-Tent Fold
por: Lupas, Andrei N., et al.
Publicado: (2015)

Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
por: Wang, Jin-Ya, et al.
Publicado: (2016)

Erratum to: Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
por: Wang, Jing-Ya, et al.
Publicado: (2016)

Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine
por: Hoffer, Barry J., et al.
Publicado: (2017)

Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice
por: Baratz, Renana, et al.
Publicado: (2015)

Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
por: Huang, Shang-Yi, et al.
Publicado: (2014)

3,6’-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation
por: Lin, Chih-Tung, et al.
Publicado: (2020)

Pomalidomide Ameliorates H(2)O(2)-Induced Oxidative Stress Injury and Cell Death in Rat Primary Cortical Neuronal Cultures by Inducing Anti-Oxidative and Anti-Apoptosis Effects
por: Tsai, Yan-Rou, et al.
Publicado: (2018)

Thalidomide upper limb embryopathy – pathogenesis, past and present management and future considerations
por: Vargesson, Neil, et al.
Publicado: (2023)

Exendin-4 Ameliorates Traumatic Brain Injury-Induced Cognitive Impairment in Rats
por: Eakin, Katharine, et al.
Publicado: (2013)

Chemical Ligand Space of Cereblon
por: Boichenko, Iuliia, et al.
Publicado: (2018)

Long-term depletion of cereblon induces mitochondrial dysfunction in cancer cells
por: Park, Seulki, et al.
Publicado: (2021)

The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary Microglia
por: Glotfelty, Elliot J., et al.
Publicado: (2023)

PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease
por: Yu, Seong-Jin, et al.
Publicado: (2020)

Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera
por: Kim, Kidae, et al.
Publicado: (2019)

Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma
por: Chang, Xiubao, et al.
Publicado: (2017)

Structural Dynamics of the Cereblon Ligand Binding Domain
por: Hartmann, Marcus D., et al.
Publicado: (2015)

Tubulin Resists Degradation by Cereblon-Recruiting PROTACs
por: Gasic, Ivana, et al.
Publicado: (2020)

UDP-glucose, cereblon-dependent proinsulin degrader
por: Cho, Jaeyong, et al.
Publicado: (2022)

Time-dependent cytokine and chemokine changes in mouse cerebral cortex following a mild traumatic brain injury
por: Tweedie, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_la4sp3pu3eprgad4kj79q40pm1